Amanda Saratsis

2.0k citations
35 papers · 1.2k indexed · h-index 16
Topics
Glioma Diagnosis and Treatment (15 papers)Chromatin Remodeling and Cancer (9 papers)Protein Degradation and Inhibitors (6 papers)

In The Last Decade

Amanda Saratsis

31 papers receiving 1.2k citations

Peers

Amanda Saratsis
Comparison fields: 5 of 67
  • Molecular Biology 710
  • Genetics 629
  • Cancer Research 301
  • Neurology 219
  • Pulmonary and Respiratory Medicine 199
Replace Britta Blaschke with:
Britta Blaschke Germany
Paul Duic United States
Roberto Hernán United States
Nancy Garren United States
Frank Mendrzyk Germany
Dominik Sturm Germany
Shoji Shiraishi Japan
Lori Frederick United States
Soufiane El Hallani Canada
Sergey Popov United Kingdom
Amanda Saratsis relative to Britta Blaschke Germany Britta Blaschke's profile →
Citations per field
00.5×7.3×
Britta Blaschke · 1×
Citations per year

Countries citing papers authored by Amanda Saratsis

Since Specialization
Citations

This map shows the geographic impact of Amanda Saratsis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Saratsis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Saratsis more than expected).

Fields of papers citing papers by Amanda Saratsis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Saratsis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Saratsis. The network helps show where Amanda Saratsis may publish in the future.

Co-authorship network of co-authors of Amanda Saratsis

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Saratsis. A scholar is included among the top collaborators of Amanda Saratsis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Saratsis. Amanda Saratsis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 13
4 12
5 12
6 50
7 48
8 3
9 52
10 21
11 22
12 26
13 6
14 32
15 275
16 130
17 100
18 14
19 80
20 71

About Amanda Saratsis

Amanda Saratsis is a scholar working on Genetics, Cancer Research and Immunology and Allergy, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (15 papers), Chromatin Remodeling and Cancer (9 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Genetics (629 citations), Cancer Research (301 citations) and Neurology (219 citations). Amanda Saratsis has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Rishi Lulla, C. David James, Craig Horbinski, Rintaro Hashizume, Ali Shilatifard, Andrea Piunti, Javad Nazarian, Tina Huang, Elizabeth T. Bartom and Jin Qi. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026